DGCRF
Price:
$0.0001
Market Cap:
$30.07K
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnostic tests designed for the identification and management of cancerous conditions. The company's portfolio includes the PCA3 test for prostate cancer diagnosis, as well as the Guanylyl Cyclase C (GCC) marker and the Previstage GCC colorectal cancer staging test, both vital for patients with colorectal cancer. They also offer PCP, a multi-marker diagnostic for prostate cancer. In addition to these tests, Diagnocure provides specialized services such as gene expression and copy number variation anal...[Read more]
Industry
Medical - Specialties
IPO Date
2009-09-08
Stock Exchange
OTC
Ticker
DGCRF
According to Diagnocure, Inc.’s latest financial reports and current stock price. The company's current ROE is -110.73%. This represents a change of -165.30% compared to the average of 169.57% of the last 4 quarters.
The mean historical ROE of Diagnocure, Inc. over the last ten years is -60.16%. The current -110.73% ROE has changed 84.05% with respect to the historical average. Over the past ten years (40 quarters), DGCRF's ROE was at its highest in in the April 2016 quarter at 939.58%. The ROE was at its lowest in in the October 2015 quarter at -165.78%.
Average
-60.16%
Median
-43.50%
Minimum
-246.03%
Maximum
-9.08%
Discovering the peaks and valleys of Diagnocure, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 510.14%
Maximum Annual ROE = -9.08%
Minimum Annual Increase = -84.68%
Minimum Annual ROE = -246.03%
| Year | ROE | Change |
|---|---|---|
| 2015 | -246.03% | 510.14% |
| 2014 | -40.32% | -20.76% |
| 2013 | -50.89% | 44.51% |
| 2012 | -35.22% | 288.01% |
| 2011 | -9.08% | -84.68% |
| 2010 | -59.25% | 6.95% |
| 2009 | -55.39% | 18.69% |
| 2008 | -46.67% | 104.87% |
| 2007 | -22.78% | -36.66% |
| 2006 | -35.96% | 198.47% |
The current ROE of Diagnocure, Inc. (DGCRF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-112.41%
5-year avg
-76.31%
10-year avg
-60.16%
Diagnocure, Inc.’s ROE is less than NMC Health plc (0%), less than Rapid Therapeutic Science Laboratories, Inc. (5.89%), less than Humanigen, Inc. (199.39%), less than Cantabio Pharmaceuticals, Inc. (0%), greater than Total Brain Limited (-104.70%), less than NutraLife BioSciences, Inc. (2.83%), less than QSAM Biosciences, Inc. (1.62%), less than Hempfusion Wellness Inc. (0%), less than New You, Inc. (288.53%), greater than MagForce AG (-33.92%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $2.09K | |
| 5.89% | $883.00 | |
| 199.39% | $23.82K | |
| 0% | $22.77K | |
| -104.70% | $26.74K | |
| 2.83% | $17.66K | |
| 1.62% | $18.44K | |
| 0% | $1.64K | |
| 288.53% | $14.99K | |
| -33.92% | $11.97K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Diagnocure, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Diagnocure, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Diagnocure, Inc.'s ROE?
How is the ROE calculated for Diagnocure, Inc. (DGCRF)?
What is the highest ROE for Diagnocure, Inc. (DGCRF)?
What is the 3-year average ROE for Diagnocure, Inc. (DGCRF)?
What is the 5-year average ROE for Diagnocure, Inc. (DGCRF)?
How does the current ROE for Diagnocure, Inc. (DGCRF) compare to its historical average?